The most effective way to prevent HPV in males is vaccination, ideally before any sexual contact. The HPV vaccine reduces the incidence of external genital lesions caused by the most common strains by up to 90% in males aged 16 to 26. Beyond vaccination, condom use, circumcision, and limiting sexual partners each provide meaningful additional protection.
HPV is the most common sexually transmitted infection, and most sexually active men will acquire at least one type during their lifetime. The majority of infections clear on their own within about 7 to 12 months, but some persist and lead to serious problems. Each year in the U.S., roughly 13,600 cases of throat cancer, 2,300 cases of anal cancer, and 900 cases of penile cancer in men are attributed to HPV.
Vaccination Is the Strongest Protection
The current HPV vaccine targets nine strains of the virus, including the types responsible for most HPV-related cancers and genital warts. In clinical trials, the vaccine reduced external genital lesions linked to the four main targeted strains by 90% in young men who received all doses before exposure. In broader real-world populations where some men had already been exposed, effectiveness against genital warts still ranged from 57% to 67%.
The CDC recommends routine HPV vaccination at age 11 or 12, though it can start as early as age 9. Catch-up vaccination is recommended for all males through age 26 who weren’t fully vaccinated earlier. The dosing schedule depends on when you start:
- Before age 15: Two doses, with the second given 6 to 12 months after the first.
- Age 15 or older: Three doses. The second comes 1 to 2 months after the first, and the third follows at 6 months.
The vaccine works best when given before any sexual activity, since it prevents new infections rather than treating existing ones. But even if you’ve already been sexually active, vaccination still protects against strains you haven’t yet encountered. If you’re between 27 and 45 and never received the vaccine, it’s worth discussing with a healthcare provider, though the benefit diminishes with age because most people in that range have already been exposed to common strains.
Condoms Cut the Risk Roughly in Half
Condoms don’t eliminate HPV risk the way they do for many other STIs, because HPV spreads through skin-to-skin contact in areas a condom doesn’t fully cover. Still, consistent condom use makes a real difference. A large multinational study tracking HPV infections in men found that those who always used condoms had about half the risk of acquiring a new HPV infection compared to men who never used them (a hazard ratio of 0.54 after adjusting for other factors like age, number of partners, and smoking).
Condoms also appear to help the body clear infections faster when they do occur. This matters because persistent infections, not short-lived ones, are what lead to cancer. Using condoms consistently won’t make you immune to HPV, but it meaningfully lowers both your chances of picking up new infections and how long those infections stick around.
How Circumcision Affects HPV Risk
Male circumcision provides a substantial reduction in HPV risk. A large randomized controlled trial in Kenya found that circumcised men had approximately 40% lower incidence of new HPV infections over two years compared to uncircumcised men. HPV prevalence dropped from 50% at the start of the study to 23.7% in the circumcised group, versus 41.0% in the control group.
The protective effect goes beyond just acquiring fewer infections. Circumcised men cleared existing HPV infections at least 50% faster, and they were significantly less likely to be infected with multiple HPV types simultaneously. The foreskin provides a warm, moist environment where the virus thrives, and removing it reduces the surface area vulnerable to infection. This isn’t a decision most adult men make purely for HPV prevention, but it’s worth knowing the data if circumcision is already being considered for other reasons.
Fewer Partners Means Lower Exposure
Every new sexual partner represents a new potential source of HPV exposure. Research from a large cohort study tracking men across three countries found that the ability to clear cancer-causing HPV strains dropped significantly as lifetime partner count increased. Men with 50 or more lifetime female partners cleared oncogenic HPV infections about half as effectively as men with one or fewer partners. This likely reflects repeated reinfection and higher viral burden rather than a weakened immune response.
Reducing the number of sexual partners, or choosing partners who have had fewer partners themselves, lowers cumulative exposure. This is a numbers game: HPV is so common that risk rises with each new contact, regardless of how healthy a partner appears.
Why There’s No HPV Test for Men
One frustrating reality is that there is no approved or recommended HPV screening test for men. The HPV tests currently available are designed for cervical cancer screening in women and are not useful for men of any age, according to CDC guidelines. They should not be used for male partners of women with HPV, for diagnosing genital warts, or as a general STI screen.
This means most men with HPV never know they have it. The virus typically causes no symptoms, and the body clears the median infection in about 7.5 months. HPV 16, the strain most strongly linked to throat and other cancers, tends to persist longer, with a median duration of roughly 12 months. Without a screening tool, men can’t rely on testing to manage their risk. Prevention through vaccination, condoms, and partner selection is the primary strategy.
What HPV Can Do if It Persists
Most HPV infections in men resolve without ever causing a health problem. The concern is the small percentage that persist for years and eventually trigger cellular changes leading to cancer. Throat cancer (specifically oropharyngeal cancer) is by far the biggest HPV-related cancer risk for men, with nearly 18,800 cases diagnosed annually in the U.S., about 72% of which are caused by HPV. Anal cancer accounts for roughly 2,600 annual cases in men (89% HPV-caused), and penile cancer adds about 1,400 cases (63% HPV-caused).
Genital warts, while not dangerous, are the most visible consequence of HPV infection in men. They’re caused by low-risk HPV strains (types 6 and 11), which are covered by the current vaccine. Warts can be treated but tend to recur, and outbreaks can last months.
Stacking Prevention Strategies
No single approach eliminates HPV risk entirely, but combining strategies adds up. Vaccination before exposure is the foundation. Consistent condom use roughly halves the remaining risk. Circumcision provides an additional 40% reduction in new infections. And limiting the number of sexual partners reduces cumulative exposure over a lifetime.
Smoking is also worth mentioning here: it impairs the immune system’s ability to clear HPV infections, which is one reason it shows up as a risk factor in HPV-related cancer studies. Quitting smoking or never starting supports your body’s natural ability to suppress the virus if you’re exposed. For men who are past the ideal vaccination window and already sexually active, the combination of condoms, healthy immune function, and awareness of symptoms (persistent sore throat, unusual growths, non-healing sores) remains the practical toolkit.